Endothelium-dependent and -independent vasorelaxant actions and mechanisms induced by total flavonoids of Elsholtzia splendens in rat aortas

Environ Toxicol Pharmacol. 2014 Sep;38(2):453-9. doi: 10.1016/j.etap.2014.07.019. Epub 2014 Aug 4.

Abstract

Elsholtzia splendens (ES) is, rich in flavonoids, used to repair copper contaminated soil in China, which has been reported to benefit cardiovascular systems as folk medicine. However, few direct evidences have been found to clarify the vasorelaxation effect of total flavonoids of ES (TFES). The vasoactive effect of TFES and its underlying mechanisms in rat thoracic aortas were investigated using the organ bath system. TFES (5-200mg/L) caused a concentration-dependent vasorelaxation in endothelium-intact rings, which was not abolished but significantly reduced by the removal of endothelium. The nitric oxide synthase (NOS) inhibitor N(ω)-nitro-l-arginine methyl ester (100μM) and the guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,2-α]quinoxalin-1-one (30μM) significantly blocked the endothelium-dependent vasorelaxation of TFES. Meanwhile, NOS activity in endothelium-intact aortas was concentration-dependently elevated by TFES. However, indomethacin (10μM) did not affect TFES-induced vasorelaxation. Endothelium-independent vasorelaxation of TFES was significantly attenuated by KATP channel blocker glibenclamide. The accumulative Ca(2+)-induced contraction in endothelium-denuded aortic rings primed with KCl or phenylephrine was markedly weakened by TFES. These results revealed that the NOS/NO/cGMP pathway is likely involved in the endothelium-dependent vasorelaxation induced by TFES, while activating KATP channel, inhibiting intracellular Ca(2+) release, blocking Ca(2+) channels and decreasing Ca(2+) influx into vascular smooth muscle cells might contribute to the endothelium-independent vasorelaxation conferred by TFES.

Keywords: Aorta; Calcium channels; Endothelium; Potassium channels; Total flavonoids of Elsholtzia splendens; Vasorelaxation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta, Thoracic / cytology
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / enzymology*
  • China
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / enzymology
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / administration & dosage*
  • Flavonoids / pharmacology
  • Gene Expression Regulation / drug effects
  • Indomethacin / administration & dosage
  • Indomethacin / pharmacology
  • Male
  • Nitric Oxide Synthase / metabolism
  • Plants, Medicinal / chemistry
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects*
  • Tracheophyta / chemistry*
  • Vasodilation / drug effects*
  • Vasodilator Agents / administration & dosage*
  • Vasodilator Agents / pharmacology

Substances

  • Enzyme Inhibitors
  • Flavonoids
  • Vasodilator Agents
  • Nitric Oxide Synthase
  • Indomethacin